- Report
- November 2023
- 77 Pages
France
From €3140EUR$3,500USD£2,684GBP
- Report
- January 2024
- 200 Pages
Global
From €3723EUR$4,150USD£3,183GBP
- Report
- July 2023
- 115 Pages
Global
From €4037EUR$4,500USD£3,451GBP
- Report
- November 2022
- 70 Pages
Global
From €1749EUR$1,950USD£1,495GBP
- Report
- October 2025
- 150 Pages
Germany
From €4351EUR$4,850USD£3,719GBP
- Report
- August 2025
- 150 Pages
Global
From €2835EUR$3,160USD£2,423GBP
€3543EUR$3,950USD£3,029GBP
- Report
- March 2025
- 87 Pages
Global
From €3500EUR$4,180USD£3,097GBP
From €4037EUR$4,500USD£3,451GBP
- Report
- July 2024
- 132 Pages
Global
From €852EUR$950USD£729GBP
The mRNA Therapeutics market is a subset of the larger Genomics market, which focuses on the development of therapeutics based on messenger RNA (mRNA). mRNA is a type of genetic material that is used to produce proteins in cells. mRNA Therapeutics are designed to target specific diseases by delivering mRNA molecules to cells, which can then be used to produce proteins that can treat or prevent the disease. mRNA Therapeutics have the potential to revolutionize the way diseases are treated, as they can be used to target specific diseases without affecting other parts of the body.
The mRNA Therapeutics market is still in its early stages, but is expected to grow rapidly in the coming years. Companies in the market are focused on developing mRNA-based therapeutics for a variety of diseases, including cancer, cardiovascular diseases, and neurological disorders.
Some of the companies in the mRNA Therapeutics market include Moderna, CureVac, Arcturus Therapeutics, and BioNTech. Show Less Read more
